Last $3.79 USD
Change Today -0.13 / -3.32%
Volume 63.0K
FHCO On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ CM
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

female health company (FHCO) Snapshot

Open
$3.87
Previous Close
$3.92
Day High
$3.99
Day Low
$3.79
52 Week High
03/31/14 - $7.92
52 Week Low
10/1/14 - $3.31
Market Cap
109.2M
Average Volume 10 Days
66.2K
EPS TTM
$0.08
Shares Outstanding
28.8M
EX-Date
07/14/14
P/E TM
47.4x
Dividend
--
Dividend Yield
3.69%
Current Stock Chart for FEMALE HEALTH COMPANY (FHCO)

female health company (FHCO) Related Bloomberg News

View More Bloomberg News

female health company (FHCO) Related Businessweek News

No Related Businessweek News Found

female health company (FHCO) Details

The Female Health Company develops, manufactures, and markets consumer health care products. It offers the FC2 female condom that provides women dual protection against unintended pregnancy and sexually transmitted infections, including HIV/AIDS. The company sells its products to global agencies, non-government organizations, ministries of health, and other government agencies directly, as well as through distribution agreements and other arrangements with commercial partners. It operates in South Africa, Angola, Brazil, Uganda, Nigeria, Zimbabwe, Tanzania, the United States, Brazil, Malaysia, the Democratic Republic of the Congo, and internationally. The company was founded in 1896 and is headquartered in Chicago, Illinois.

149 Employees
Last Reported Date: 12/2/14
Founded in 1896

female health company (FHCO) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $245.5K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $207.5K
Consultant
Total Annual Compensation: $137.7K
Executive Vice President of Sales and Marketi...
Total Annual Compensation: $101.4K
Compensation as of Fiscal Year 2014.

female health company (FHCO) Key Developments

The Female Health Company Receives Orders for 25 Million FC2 from Brazil

The Female Health Company announced that, its exclusive distributor in Brazil, Semina Industria e Comercio Ltda has placed orders for 25 million FC2 Female Condoms.

The Female Health Company Presents at Sidoti & Company Emerging Growth Institutional Investor Forum, Jan-12-2015 09:20 AM

The Female Health Company Presents at Sidoti & Company Emerging Growth Institutional Investor Forum, Jan-12-2015 09:20 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Karen L. King, Chief Executive Officer, President and Director, Michele Greco, Chief Financial Officer, Principal Accounting Officer and Executive Vice President.

The Female Health Company Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended September 30, 2014

The Female Health Company announced unaudited consolidated earnings results for the fourth quarter and year ended September 30, 2014. For the quarter, the company reported net revenue of $5,554,113 against $4,789,187 a year ago. Operating loss was $482,577 against operating income of $1,741,980 a year ago. Loss before income taxes was $497,085 against income before income taxes of $1,710,444 a year ago. Net loss was $566,121 against net income of $6,590,172 a year ago. Net loss per basic and diluted common share outstanding was $0.02 against net income per basic and diluted common share outstanding $0.23 a year ago. For the year, the company reported net revenue of $24,490,586 against $31,456,778 a year ago. Operating income was $3,923,912 against $9,789,597 a year ago. Income before income taxes was $3,957,191 against $9,933,854 a year ago. Net income was $2,433,061 against $14,342,598 a year ago. Net income per diluted common share outstanding was $0.08 against $0.50 a year ago. The company generated $3.7 million in positive cash flow from operations. The decline in net Revenue was partially due to large shipments to Brazil in fiscal year 2013 that did not recur in fiscal year 2014. The decrease in operating income was primarily due to lower unit sales and increased spending on sales, marketing, training and educational activities. The majority of such increased spending relates to payments to the company's Brazilian distributor for programming related to the 2012 tender and for management services for the recently announced 2014 tender.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FHCO:US $3.79 USD -0.13

FHCO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FHCO.
View Industry Companies
 

Industry Analysis

FHCO

Industry Average

Valuation FHCO Industry Range
Price/Earnings 45.0x
Price/Sales 4.4x
Price/Book 3.9x
Price/Cash Flow 44.9x
TEV/Sales 4.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FEMALE HEALTH COMPANY, please visit www.femalehealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.